Avidicure
PrivateLast Round
Seed
Apr 24, 2025
Total Funding Raised
$50M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Avidicure is a biotechnology company that develops a dual agonistic, multifunctional antibody modality designed to engage immune cells for targeted cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avidicure Comparables
Compare Avidicure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Revitope Oncology, Inc. | 78% | |
| Biomunex Pharmaceuticals | 78% | |
| Merus N.V. | 73% | |
Avidicure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 24, 2025 |
Key People
Founding team and executive leadership
Avidicure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Seed |
| EQT Life Sciences | Seed |
| V-Bio Ventures | Seed |
| BioGeneration Ventures | Seed |
| Kurma Partners | Seed |
| Curie Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 2720% MoM, from 45 to 1.3K.
- Apr 24, 2025
$50M round led by EQT Life Sciences
Avidicure Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avidicure's valuation, stock price, and market status.